Premium
Characterization of ZAG protein expression in prostate cancer using a semi‐automated microscope system
Author(s) -
Descazeaud Aurelien,
de la Taille Alexandre,
Allory Yves,
Faucon Hugo,
Salomon Laurent,
Bismar Tarek,
Kim Robert,
Hofer Matthias D.,
Chopin Dominique,
Abbou Claude C.,
Rubin Mark A.
Publication year - 2006
Publication title -
the prostate
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.295
H-Index - 123
eISSN - 1097-0045
pISSN - 0270-4137
DOI - 10.1002/pros.20405
Subject(s) - prostate cancer , tissue microarray , prostate , immunohistochemistry , medicine , biochemical recurrence , pathology , protein expression , oncology , surgical margin , cancer , prostatectomy , biology , gene , biochemistry
OBJECTIVE Zinc‐alpha‐2‐glycoprotein 1 (ZAG) is a 41‐kD secreted protein that is known to stimulate lipid degradation in adipocytes. The aim of this study was to determine how ZAG protein expression is associated with prostate cancer (PCa). MATERIALS AND METHODS An immunohistochemistry analysis was performed on a 227 PCa tissue microarray cases. ZAG protein expression was assessed using a semi‐automated cellular image analysis system. RESULTS ZAG expression was associated with tumor stage (pT2 > pT3 > metastasis cases, P < 0.001), and was inversely associated with Gleason score on pathology ( P = 0.01). ZAG intensity was predictive of biochemical recurrence ( P = 0.002). On multivariate analysis including pT2 patients, the predictive factors of biochemical recurrence were ZAG expression ( P = 0.016), Gleason score ( P = 0.011), and surgical margin status ( P = 0.047). CONCLUSIONS This study characterized ZAG protein expression in PCa using a semi‐automated system. ZAG expression level found to have an independent prognostic value for pT2 patients. Prostate 66: 1037–1043, 2006. © 2006 Wiley‐Liss, Inc.